Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients - Quiz - MDSpire

Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients

  • By

  • Makoto Hibino

  • Ayumi Shintani

  • Hiroyuki Murayama

  • Nobuyuki Morikawa

  • Kazunari Maeda

  • Sho Nishiguchi

  • Eiji Monma

  • Hiromasa Harada

  • Tsunekazu Takagi

  • Satoshi Kuroyanagi

  • Kiyoshi Endo

  • Yasushi Terada

  • Masahiro Kinoshita

  • Takahiro Yoden

  • Shogo Miyazawa

  • Shinichi Higashiue

  • May 15, 2026

  • 0 min

Share

Original Source(s)

Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients

  • by Makoto Hibino, Ayumi Shintani, Hiroyuki Murayama, Nobuyuki Morikawa, Kazunari Maeda, Sho Nishiguchi, Eiji Monma, Hiromasa Harada, Tsunekazu Takagi, Satoshi Kuroyanagi, Kiyoshi Endo, Yasushi Terada, Masahiro Kinoshita, Takahiro Yoden, Shogo Miyazawa, Shinichi Higashiue

  • May 15, 2026

Related Content

MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infection

Beyond recovery: long-term cardiovascular risks after severe COVID-19 requiring intensive care

Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra